Immunoglobulin Replacement Therapy Market - Historic Data (2019-2024), Global Trends 2025, Growth Forecasts 2037
Immunoglobulin Replacement Therapy Market in 2025 is assessed at USD 14.31 billion. The global Market size was worth more than USD 13.51 billion in 2024 and is poised to witness a CAGR of around 7.4%, crossing USD 34.18 billion revenue by 2037. North America is likely to generate USD 12.3 billion by 2037, attributed to well-developed healthcare infrastructure and the prevalence of diseases requiring immunoglobulin therapies.
The market for the therapy has increased because of the rising number of patients with auto-immune diseases such as IVIG and Guillain-Barré Syndrome, as well as the clinical effectiveness of immunoglobulin in treating these problems. Hence, the increasing frequency of these diseases will escalate the growth of the market. According to a report every year, about 100,000 people globally contract GBS. Also, the predicted incidence of GBS in 2020 was 1.41 cases per 100,000 people a year, up from 0.89 cases in 2019. In 2021, the overall rate of GBS rose by 59%.
Furthermore, the market is driven by the rising incidence of immunodeficiency illnesses. Moreover, the increased prevalence of lifestyle-related issues like obesity and antibody deficiency illnesses are also propelling the market growth. Since immunoglobulin (IgG) replacement therapy is the only viable and effective treatment option currently on the market, demand for it is rising. The immunoglobulin (IgG) replacement therapy market is anticipated to expand quickly throughout the projected period.
